Literature DB >> 16759662

Multi-residue analysis of pharmaceuticals in wastewater by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.

Mira Petrovic1, Meritxell Gros, Damia Barcelo.   

Abstract

In this work, a new multi-residue method using ultra-performance liquid chromatography (UPLC) quadrupole-time-of-flight mass spectrometry (Q-TOF-MS) was developed for screening and confirmation of 29 pharmaceutical compounds belonging to different therapeutical classes: analgesics and antiinflammatories, lipid regulating agents cholesterol lowering statin agents, psychiatric drugs, anti ulcer agents, histamine H2 receptor antagonist, antibiotics and beta-blockers. UPLC uses columns packed with 1.7 microm particles and enables elution of sample components in much narrower, more concentrated bands, resulting in better chromatographic resolution and increased peak height. The typical peak width was 5-10s at base, permitting very good separation of all compounds in 10 min, which represented an approximate three-fold reduction in the analysis time in comparison to conventional high-performance liquid chromatography (HPLC). Unequivocal identification of target pharmaceutical compounds was based on accurate mass measurement of the molecular ions in the TOF mode and by performing collision induced dissociation (CID) in the Q-TOF mode in order to generate accurate mass measurement of the product ions. Using lock mass correction the accurate masses calculated for the product ions deviated from the theoretical masses by 0.2 to 1.3 mDa (root mean square (RMS) value=0.67) and 0.7-6.4 ppm (RMS=3.53), respectively. Quantitation was carried out working in the TOF mode using the narrow window extracted ion chromatograms (nwXICs) of each compound (extracted using a 20 mDa window) yielding relative standard deviation (RSD) from 0.5 to 5.3% (run-to-run) and from 2.1 to 9.1% (day-to-day) and instrumental detection limits (IDLs) from 1 to 200 pg. Analysis of wastewater treatment plant (WWTP) samples gave method detection limits (MDLs) ranging from 10 to 500 ng/L. The UPLC-Q-TOF method was successfully applied to analyze pharmaceutical residues in WWTP samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759662     DOI: 10.1016/j.chroma.2006.05.024

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  9 in total

1.  Pharmaceuticals on a sewage impacted section of a Mediterranean River (Llobregat River, NE Spain) and their relationship with hydrological conditions.

Authors:  Victoria Osorio; Sandra Pérez; Antoni Ginebreda; Damià Barceló
Journal:  Environ Sci Pollut Res Int       Date:  2012-04-29       Impact factor: 4.223

2.  Determination of testosterone and its photodegradation products in surface waters using solid-phase extraction followed by LC-MS/MS analysis.

Authors:  Emmanuelle Vulliet; Barbara Giroud; Pedro Marote
Journal:  Environ Sci Pollut Res Int       Date:  2012-06-24       Impact factor: 4.223

3.  Highly-parallel metabolomics approaches using LC-MS for pharmaceutical and environmental analysis.

Authors:  Sunil Bajad; Vladimir Shulaev
Journal:  Trends Analyt Chem       Date:  2007-06-01       Impact factor: 12.296

4.  Pharmaceuticals in a temperate forest-water reuse system.

Authors:  Andrew D McEachran; Damian Shea; Elizabeth Guthrie Nichols
Journal:  Sci Total Environ       Date:  2017-01-08       Impact factor: 7.963

5.  Phytotoxicity of 15 common pharmaceuticals on the germination of Lactuca sativa and photosynthesis of Chlamydomonas reinhardtii.

Authors:  Ma Rosa Pino; Selene Muñiz; Jonatan Val; Enrique Navarro
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-24       Impact factor: 4.223

Review 6.  Procedures of determining organic trace compounds in municipal sewage sludge-a review.

Authors:  Petra C Lindholm-Lehto; Heidi S J Ahkola; Juha S Knuutinen
Journal:  Environ Sci Pollut Res Int       Date:  2016-12-13       Impact factor: 4.223

7.  Theoretical investigation of loratadine reactivity in order to understand its degradation properties: DFT and MD study.

Authors:  Stevan Armaković; Sanja J Armaković; Biljana F Abramović
Journal:  J Mol Model       Date:  2016-09-17       Impact factor: 1.810

8.  Identification of CM1 as a Pathogenic Factor in Inflammatory Diseases and Cancer.

Authors:  Seyeon Bae; Hyemin Kim; Yeon Sil Yu; Na-Eun Lee; Joo Myoung Kong; Hang-Rae Kim; Young-Il Hwang; Yeong Wook Song; Jae Seung Kang; Wang Jae Lee
Journal:  Immune Netw       Date:  2011-06-30       Impact factor: 6.303

Review 9.  A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment.

Authors:  Ramiro Picoli Nippes; Paula Derksen Macruz; Gabriela Nascimento da Silva; Mara Heloisa Neves Olsen Scaliante
Journal:  Process Saf Environ Prot       Date:  2021-06-30       Impact factor: 6.158

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.